METROPOLITAN LIFE INSURANCE CO/NY - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$61,457
-32.1%
48,391
+16.5%
0.00%0.0%
Q3 2021$90,531
-21.0%
41,528
+35.8%
0.00%
-50.0%
Q2 2021$114,664
-8.5%
30,577
-20.5%
0.00%0.0%
Q1 2021$125,363
-13.3%
38,455
-9.3%
0.00%0.0%
Q4 2020$144,557
-17.1%
42,392
-0.8%
0.00%
-33.3%
Q3 2020$174,400
+35.9%
42,745
+12.6%
0.00%
+50.0%
Q2 2020$128,335
+44.4%
37,969
-0.4%
0.00%0.0%
Q1 2020$88,845
-32.0%
38,131
+6.2%
0.00%0.0%
Q4 2019$130,720
-58.1%
35,912
-4.4%
0.00%
-60.0%
Q3 2019$311,668
+8.1%
37,573
+12.2%
0.01%0.0%
Q2 2019$288,211
-16.7%
33,474
+3.4%
0.01%
-16.7%
Q1 2019$346,025
+22.2%
32,3690.0%0.01%0.0%
Q4 2018$283,229
-47.9%
32,3690.0%0.01%
-40.0%
Q3 2018$543,799
-99.9%
32,3690.0%0.01%
-9.1%
Q2 2018$678,454,000
+49.6%
32,369
+14.8%
0.01%
+83.3%
Q1 2018$453,545,000
+86952.8%
28,188
+2.5%
0.01%
-14.3%
Q4 2017$521,000
-36.6%
27,512
-52.9%
0.01%
+40.0%
Q3 2017$822,000
+87.7%
58,400
-0.7%
0.01%
+66.7%
Q2 2017$438,000
+14.7%
58,8310.0%0.00%0.0%
Q1 2017$382,000
+60.5%
58,831
+9.5%
0.00%
+50.0%
Q4 2016$238,000
-14.1%
53,720
-9.4%
0.00%0.0%
Q3 2016$277,000
-16.3%
59,287
+17.7%
0.00%0.0%
Q2 2016$331,000
+11.8%
50,358
+8.2%
0.00%0.0%
Q1 2016$296,000
+5.3%
46,5550.0%0.00%0.0%
Q4 2015$281,000
+1.1%
46,5550.0%0.00%0.0%
Q3 2015$278,000
-9.2%
46,555
+4.0%
0.00%0.0%
Q2 2015$306,000
+2.7%
44,768
-8.8%
0.00%0.0%
Q1 2015$298,000
-12.6%
49,090
-0.1%
0.00%0.0%
Q4 2014$341,000
-14.8%
49,1350.0%0.00%
-33.3%
Q3 2014$400,000
+0.3%
49,1350.0%0.00%0.0%
Q2 2014$399,000
+3.6%
49,1350.0%0.00%0.0%
Q1 2014$385,000
-11.5%
49,1350.0%0.00%0.0%
Q4 2013$435,000
+5.6%
49,1350.0%0.00%0.0%
Q3 2013$412,000
+12.3%
49,1350.0%0.00%0.0%
Q2 2013$367,00049,1350.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders